Category: Cancer Treatment
United States Cancer Treatment
-
Prostate Cancer Diagnostics
... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$10.0 Billion by ... Read More
-
2024 United States Cancer Biomarkers Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 United States Cancer Registry Software Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 United States Cancer-Tumor Profiling Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
United States Veterinary Oncology Market By Animal Type (Canine, Feline, Equine), By Therapy (Radiotherapy, Surgery, Chemotherapy, Immunotherapy and Other Therapies), By Cancer Type (Skin Cancers, Lymphomas, Sarcomas and Others), By Region, Competition, Forecast & Opportunities, 2019-2029F
... 2019-2029F United States Veterinary Oncology Market was valued at USD 450.63 Million in 2023 and is expected to reach USD 644.03 Million by 2029 with a CAGR of 6.09% during the forecast period. The United ... Read More
-
United States In-Vitro Diagnostics (IVD) Market, By Product and Services (Reagents & Kits, Instruments, Software & Services); By Technique (Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Immunodiagnostics, Hematology, Others); By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others); By End User (Standalone Laboratories, Hospitals, Academic & Medical Schools, Point of Care (PoC), Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others); By End User (Standalone Laboratories, Hospitals, Academic & Medical Schools, Point of Care (PoC), Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 United States In-Vitro Diagnostics (IVD) ... Read More
-
2024 US Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
... pages and 50 tables. The report presents a comprehensive analysis of the US hospital cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and ... Read More
-
Health Fundraising Organizations - 2024 U.S. Market Research Report with Updated Recession Risk Forecasts
... in the United States with over 100+ data sets covering 2015-2028. This Kentley Insights report is full of industry insights including historical and forecasted market size, revenue and industry breakdowns by product lines, size of ... Read More
-
2024 What's Next for US Diagnostics Market? - Supplier Shares and Strategies, 2023-2028 Volume and Sales Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2023 supplier shares, strategies, as well as 2023-2028 volume and sales forecasts for 500 ... Read More
-
2024 North America Nucleic Acid Testing (NAT) Market Opportunities in the US, Canada, Mexico - Competitive Shares and Growth Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests - Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks
... - Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is designed to help current suppliers and ... Read More
-
2024 U.S. Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and R
... is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products for diagnosing genetic diseases, cancer, as well as forensic and paternity/HLA testing during the ... Read More
-
2024 Global Molecular Diagnostics Market in the US, Europe, Japan - 2023 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Pater
... Tests This database from LeadingMarketResearch.com provides the 2023 supplier shares, the 2023-2028 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies ... Read More
-
2024 U.S. Molecular Diagnostics Market: 2023 Supplier Shares, Instrumentation Installed Base and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... supplier shares, the 2023-2028 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for ... Read More
-
2024 North America Molecular Diagnostics Market in the US, Canada, Mexico - 2023 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic a
... Paternity Tests This database from LeadingMarketResearch.com provides the 2023 supplier shares, the 2023-2028 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of ... Read More
-
2024 North America Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics Market—Growth Opportunities in the US, Canada, Mexico - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Instrumentation Pipeline,
... Barriers and Risks This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products for diagnosing genetic diseases, cancer, as well as ... Read More
-
Oncologists in the US - Industry Market Research Report
... size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares. Read More
-
2024 North America Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Canada, Mexico - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new 3-country report from LeadingMarketResearch.com.This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and ... Read More
-
U.S. Cancer Contrast Media Market Size - By Product Type (Gadolinium-based Contrast Media, Iodinated Contrast Media), Modality (Nuclear Imaging, CT, MRI, Mammography), Application (Breast Cancer, Bladder Cancer, Lung Cancer), End-use & Forecast, 2024 - 2032
... U.S. Cancer Contrast Media Market size is poised to expand at 4.9% CAGR between 2024 and 2032 driven by the continuous technological advancements in imaging and the launch of new products. Innovations in MRI and ... Read More
-
North America Cancer Biopsy Market, By Product (Instruments, Kits and Consumables, Services), By Type (Tissue Biopsy, Surgical Biopsy, Liquid Biopsy, Others), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancers, Others (Including Liver Cancer, Blood Cancer, Prostate Cancer)), By End User (Hospitals, Diagnostic Laboratories, Others), By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Blood Cancer, Prostate Cancer)), By End User (Hospitals, Diagnostic Laboratories, Others), By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 North America Cancer Biopsy Market Size Set Expands at Significant CAGR of ... Read More
-
North America Cancer Diagnostics Market, By Products (Instruments, Consumables Services), By Test Type (Imaging Tests, Biopsy and Cytology Tests, Tumor Biomarkers, Immunohistochemistry, In Situ Hybridization and Others (Endoscopy, Genetic Tests)), By Application (Breast Cancer, Cervical Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Liver Cancer, Others (Including Skin Cancer, Colorectal Cancer, Prostate Cancer, etc.)), By End User (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, Others), By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Liver Cancer, Others (Including Skin Cancer, Colorectal Cancer, Prostate Cancer, etc.)), By End User (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, Others), By Country (United ... Read More
-
2024 Global Clinical Chemistry and Immunodiagnostics Market in the US, Europe, Japan - 2023 Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Te
... TDM Tests This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), ... Read More
-
2024 North America Clinical Chemistry and Immunodiagnostics Market in the US, Canada and Mexico - 2023 Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein
... Immunoprotein and TDM Tests This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, ... Read More
-
U.S. Cancer Contrast Media Market Size, Share & Trends Analysis Report By Type (Gadolinium-based Contrast Media, Iodinated Contrast Media), By Modality (Nuclear Imaging, CT scans), By Application (Breast Cancer, Lung Cancer), And Segment Forecasts, 2024 -
... - U.S. Cancer Contrast Media Market Growth & Trends The U.S. cancer contrast media market is anticipated to reach USD 1.53 billion by 2030 and is anticipated to expand at a CAGR of 11.7% from ... Read More
-
Oncologists Global Market Opportunities And Strategies To 2032 Including: 1) By Cancer Diagnosis And Treatment: Cancer Diagnosis; Cancer Treatment 2) By Indication: Lungs Cancer; Colorectal Cancer; Breast Cancer; Liver Cancer; Bladder Cancer; Head And Neck Cancer; Prostate Cancer 3) By Service Provider: Hospitals; Diagnostic Laboratories; Diagnostic Imaging Centers; Specialty Clinics; Academia Covering: Kaiser Foundation Health Plan, Inc.; HCA Healthcare, Inc.; The University of Texas MD Anderson Cancer Center; Tenet Healthcare Corporation; Universal Health Services, Inc.
... Cancer3) By Service Provider: Hospitals; Diagnostic Laboratories; Diagnostic Imaging Centers; Specialty Clinics; AcademiaCovering: Kaiser Foundation Health Plan, Inc.; HCA Healthcare, Inc.; The University of Texas MD Anderson Cancer Center; Tenet Healthcare Corporation; Universal Health Services, ... Read More
-
NA Acute Myeloid Leukemia Diagnostics Market - Industry Trends and Forecast to 2035
... to 2031. The new market report contains data for the historic year 2022, the base year of calculation is 2023, and the forecast period is 2024 to 2031. Market Segmentation North America Acute Myeloid Leukemia ... Read More
Research Assistance
